GLENMARK PHARMACEUTICALS LIMITED — Investor Relations & Filings

Glenmark Pharmaceuticals Limited is a global, research-led pharmaceutical company. It develops, manufactures, and markets a diverse portfolio of innovative, branded, specialty, generic, and over-the-counter medicines. The company is driven by a dual mission: pioneering transformative, breakthrough therapies and expanding access to high-quality, essential medicines for patients worldwide. Its innovative and specialty pipeline is strategically focused on therapeutic areas such as Respiratory, Dermatology, and Oncology, where it leverages deep scientific expertise and global partnerships. Glenmark emphasizes scientific excellence, responsible execution, and commercial agility to address unmet patient needs and improve global health outcomes.